SEC Form 4 · accession 0001179110-16-033197
Traws Pharma, Inc. · TRAW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ramesh Kumar
Officer — President and CEO · Director
Period of report
Dec 15, 2016
Accepted (ET)
Dec 19, 2016 · 4:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001130598
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to purchase)F1 | $2.65 | Dec 15, 2016 | A | 12,673 | A | — | Dec 15, 2026 | Common Stock | 12,673 | 12,673 | D |
Explanation of responses
- F1These options vest over three years in 36 equal monthly installments.